Inherited Cancer Registry (ICARE)  

Inherited Cancer Registry (ICARE)

  • Home
  • Our Team
  • Participants & Providers
    • Participants
    • Providers
  • Newsletters
    • Newsletter Editions
    • Search Articles & Posts
  • Webinars
    • Case Conference Schedule
    • Case Conference Videos
    • Other Cancer Genetics Webinars
  • Our Research
    • B-GREAT Initiative
    • Hereditary Breast Cancer Study
    • IMPACT Study
    • TIPS Study
    • Publications
  • Contact

ICARE Social Media Post July 2021

PALB2 & Prostate Cancer

ICARE Social Media Post July 2021

RAD51C & RAD51D Response to Rucaparib in Ovarian Cancer

ICARE Social Media Post July 2021

Advances in Pancreatic Cancer Treatment: PALB2 & BRCA1/2

  • By admin in Newsletter Articles & Posts

For more information, view the article at the following link below: https://ascopubs.org/doi/abs/10.1200/JCO.21.00003

You may also read the ASCO post article at: https://ascopost.com/news/may-2021/maintenance-rucaparib-in-patients-with-platinum-sensitive-pancreatic-cancer-and-germline-or-somatic-brca1-brca2-or-palb2-variants/?utm_source=TAP%2DEN%2D051221%2DTrending%5FLymphoma&utm_medium=email&utm_term=49cf1c97d48c2cf8231827e3bcb15769

  • BRCA1, BRCA2, Cancer Treatment, PALB2, Pancreatic Cancer, PARP Inhibitors, Social Media

admin

Permanent link to this article: https://inheritedcancer.net/post70621/

Made with by Graphene Themes.